USA suM,MARY Most recent studies discussing tachycardias with alternating QRS polarity have referred to those known as torsade de pointes. This report, in contrast, deals with bidirectional tachycardia and the effects of lignocaine on 10 patients with this arrhythmia. Three of the patients also had digitalisinduced atrial tachycardia with block. In one patient, a single bolus of lignocaine was followed (five minutes later) by ventricular fibrillation, but the other nine patients received two boluses of 75 mg followed by a drip infusion of 3 mg/min. The drug terminated the episodes of atrial tachycardia with block and bidirectional tachycardia in all patients thus treated. Whereas the abolition of the bidirectional tachycardia was permanent in the seven patients with digitalis intoxication, it recurred after stopping the drip infusion in the two patients without digitalis toxicity. It is concluded that lignocaine can be useful in the treatment of digitalis-induced bidirectional tachycardia and atrial tachycardia with block. From this study no conclusions can be drawn, however, as to whether lignocaine is superior to other class I or class IV agents.
Few papers published during the last 15 years have discussed the treatment of bidirectional tachycardia. [1] [2] [3] [4] [5] [6] [7] Since most articles appeared before the use of lignocaine became widespread, it seemed of interest to present our experience with this drug in patients with' bidirectional tachycardia, placing additional emphasis on the effects of lignocaine on digitalisinduced atrial tachycardia with block.
Subjects and methods
For the purpose of this paper, bidirectional tachycardia was considered as an electrocardiographic pattern resulting from the existence (or coexistence) of one or more ectopic (atrioventricular junctional or ventricular) rhythms with the following characteristics ( There were 10 patients with bidirectional tachycardia but the effects of properly administered intravenous lignocaine were studied in only nine since in case 1 ventricular fibrillation appeared about five minutes after administration of a single bolus of 75 mg (Fig. 2) . In these nine patients an initial 75 mg bolus was followed three minutes later by a second 75 mg bolus, at which time a drip infusion (of 3 mg/ min) was started. The infusion was maintained for a seven hour period during which time the patients were continuously monitored in an intensive care unit by trained personnel.
In the Table, His bundle recordings performed (in three cases) while the bidirectional tachycardia was occurring intermittently disclosed that in sinus beats there was a properly timed H deflection in front of the corresponding ventricular complexes. The ventricular origin of bidirectional tachycardia was corroborated in two of these patients because the wide QRS complexes were not preceded by H deflections. The remaining patient with normal HV intervals in sinus beats (50 ms), however, had short HV intervals during bidirectional tachycardia. Fig. 3 (left panel) depicts a short HV interval of 30 ms in the beat having a left posterior hemiblock/"incomplete" right bundlebranch block pattern and an HV interval of 0 ms in the beats with a left anterior hemiblock/"incomplete" right bundle-branch block morphology. This suggested that impulse formation occurred below the His bundle, presumably in two left "fascicular" sites.
Conceptually, "fascicular" rhythms (or tachycardias) are "ventricular" since they arise below the bifurcation of the His bundle.9 10 EFFECTS OF LIGNOCAINE BOLUSES (Table) The initial two boluses had the following effects: (a) permanent suppression in one patient; (b) transient abolition with subsequent recurrences in four patients ( Fig. 1 and 3) ; and (c) neither transient nor permanent suppression in four patients (Fig. 4) . (Table) Eight patients still had some episodes of bidirectional tachycardia while the drip infusion of lignocaine was being administered. Whereas in two of these eight patients bidirectional tachycardia was abolished in an "all-or-none" fashion (that is, with both types of complexes disappearing at the same time), in the remaining six patients termination occurred more gradually. The infusion. The left panel shows a sinus beat followed by the first two beats of the bidirectional tachycardia. Whereas the first (apparently normalfor this patient) HV interval is 50 ms, the HV intervals ofthe second and third (ectopic) beats are shorter than normal (30 and 0 ms, respectively). The latter, when associated with an "incomplete" right bundle-branch block "pattern" in lead VI, suggests a "fascicular" (ventricular) orgin.
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EFFECTS OF LIGNOCAINE
Lignocaine (a class I agent) was used because in our hospital this is the drug first administered to treat those arrhythmias initially diagnosed as "ventricular". Thus, no conclusions can be drawn as to whether lignocaine is superior to potassium salts, drugs that cause depression of slow inward calcium current, or other class I agents such as diphenylhydantoin, procainamide, and quinidine."1 Class I agents act essentially by depressing the fast inward sodium current (fast response)." They decrease action potential amplitude, prolong the effective refractory period, and depress phase 4 depolarisation. Lignocaine and diphenylhydantoin, however, shorten action potential duration while procainamide and quinidine lengthen it."
According to Vaughan-Williams, lignocaine shortens action potential duration in those fibres where it was previously longest. Hence, action potential duration becomes more uniform. " This effect, combined with the depression of phase 4 depolarisation, may have been responsible for the suppression of the arrhythmias occurring in our patients (which could have resulted from the association of automaticity and conduction disturbances).
In all cases, lignocaine proved to be effective when it could be administered adequately according to its well known pharmacological properties. 1215 The clinical course, and the plasma concentrations of lignocaine that were observed in two patients, suggested that the effectiveness of this drug was indeed related to its pharmacokinetics. '3 15 For example, it is known that after a single intravenous injection, lignocaine follows a two-compartment exponential disappearance curve.'4 Diffusion through the body from the central compartment is first order, with a distribution half time of five to 10 minutes, equilibration through the body thereby requiring 20 to 40 minutes. The elimination of half time is around two hours. '5 Case 1 developed ventricular fibrillation five minutes after a single dose of lignocaine. It is possible that ventricular fibrillation occurred at a time when "subtherapeutic" plasma lignocaine levels were present.
The two patients with drug-unrelated bidirectional tachycardia had milder symptoms than those with digitalis-induced arrhythmias. Furthermore, bidirectional tachycardia recurred after stopping lignocaine. Thus, more studies of these types of bidirectional tachycardia appear warranted.
Lignocaine is generally not considered to be a useful drug in the treatment of supraventricular arrhythmias. '6 17 This study showed, however, that it was capable of abolishing atrial tachycardia with block caused by digitalis toxicity. Moreover, the electrocardiographic effects were similar to those produced by intravenous potassium and procainamide, as previously reported by Lown et al. 8 The initial effect of lignocaine, potassium, and procainamide is a decrease in the atrial rate which, when of sufficient magnitude, converts the second degree atrioventricular block into 1:1 atrioventricular conduction, thereby increasing the ventricular rate. This gradual decrease in the atrial rate (and therefore of the ventricular rate) continues until the sinus node takes over.
As stated by Lown et al., 8 the infusion should not be stopped when the ventricular rate increases. On the contrary, it has to be continued since this is the response expected before conversion to sinus rhythm. 
